03:16 AM EDT, 09/30/2024 (MT Newswires) -- Andrew Hollman Meyer, Chief Business Officer, on September 27, 2024, sold 50,000 shares in Janux Therapeutics ( JANX ) for $2,297,755. Following the Form 4 filing with the SEC, Meyer has control over a total of 67,592 shares of the company, with 67,592 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1817713/000141588924024078/xslF345X05/form4-09272024_110955.xml